
INFLUX
Influx Healthtech Limited
- IPO Status
- Closed
- Open Date
- 18 Jun 2025
- Close Date
- 20 Jun 2025
IPO Details
- Min. Investment
- ₹1,15,200
- Price Band
- ₹91 - ₹96
- Lot Size
- 1200 shares
- Issue Size
- ₹59 Cr
- Face Value
- 10
- IPO Doc
- —
Schedule
- IPO open18 Jun 2025
- IPO close date20 Jun 2025
- Allotment date23 Jun 2025
- Funds unblock or debit24 Jun 2025
- Listing date25 Jun 2025
Financial Performance
- Revenue
- Profit
Stocks similar to INFLUX
- Sudarshan Pharma Industries Limited
- Quest Laboratories Limited
FAQs
Influx Healthtech Limited IPO is a SME IPO aggregating up to ₹59 Cr, with equity shares of face value ₹10 each. The shares are proposed to be listed on NSE.
The Influx Healthtech Limited IPO opened on 18 Jun 2025 and closed on 20 Jun 2025. IPO Period: 18 Jun 2025 – 20 Jun 2025.
The price band for the Influx Healthtech Limited IPO is ₹91 to ₹96 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 1,200 shares. At the upper price band of ₹96, the minimum investment required is ₹1,15,200.
Particular Details Lot Size 1,200 shares Price Band ₹91 – ₹96 Minimum Investment ₹1,15,200 Here is the timeline for the Influx Healthtech Limited IPO:
IPO Event Date IPO Opens 18 Jun 2025 IPO Closes 20 Jun 2025 UPI Mandate Deadline 20 Jun 2025, 5:00 PM Basis of Allotment 23 Jun 2025 Refund Initiation 24 Jun 2025 Shares Credited 24 Jun 2025 Listing Date 25 Jun 2025 The basis of allotment for the Influx Healthtech Limited IPO is expected to be finalised on 23 Jun 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: MSPL.
The equity shares of Influx Healthtech Limited are proposed to be listed on NSE. Proposed Listing Date: 25 Jun 2025.
The key financial performance of Influx Healthtech Limited is:
Financial Year Revenue Profit FY24 ₹99.97 Cr ₹11.13 Cr FY25 ₹104.85 Cr ₹13.27 Cr FY26 ₹146.83 Cr ₹20.54 Cr Revenue CAGR: 21.2% | Profit CAGR: 35.8%. Figures are as disclosed in the company's offer documents.


